The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

An Appraisal of Tests for Native DNA Antibodies in Connective Tissue Diseases: Clinical Usefulness of Crithidia luciliae Assay

[+] Article, Author, and Disclosure Information

Grant support: USPHS Program/Project Grant AM09989 and Training Grant AM07055 and an Arthritis Foundation Clinical Study Center Grant. Dr. Chubick is a Trainee in Arthritis, Dr. Gilliam is a recipient of a USPHS Research Career Development Award, and Dr. Ziff is a recipient of a USPHS Research Career Award.

Presented in part at the XIV International Congress of Rheumatology, San Francisco, California, 1977.

▸Requests for reprints should be addressed to Andrew Chubick, M.D.; Department of Internal Medicine, University of Texas Health Science Center; 5323 Harry Hines Boulevard; Dallas, TX 75235.

Dallas, Texas

© 1978 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1978;89(2):186-192. doi:10.7326/0003-4819-89-2-186
Text Size: A A A

Antibody to native DNA was measured by five techniques: the Crithidia luciliae immunofluorescence (CL-IF) test; filter radioimmunoassays using either untreated human KB DNA, endonuclease-treated KB DNA, or a synthetic polynucleotide (poly dAT); and the Farr immunoprecipitation assay using KB DNA. The specificity and sensitivity of the CL-IF assay was similar to that of the filter radioimmunoassay procedures using KB DNA. The CL-IF test showed an increased frequency of positive tests in patients with active disease and severe renal involvement. In patients with severe renal involvement, high titers of serum nDNA antibodies were measured by this procedure. A unique advantage of the CL-IF test was its ability to identify complement-fixing nDNA antibody. The presence of such antibody was correlated with high antibody titer and the presence of severe renal disease. The CL-IF assay is a simple and useful procedure for measurement of anti-nDNA.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.